Skip to main content
Clinical Trials/CTRI/2019/08/020496
CTRI/2019/08/020496
Not yet recruiting
未知

Enhanced recovery after surgery in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis- compliance, safety & efficacy â?? a pilot study

il0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: C00-D49- Neoplasms
Sponsor
il
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
il

Eligibility Criteria

Inclusion Criteria

  • . Patients with a peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
  • ii. Peritoneal carcinomatosis Index (PCI) Score any iii. Age \>18 years and \<65 years
  • iv. European Cooperative Oncology Group (ECOG) Performance status 0\-1
  • vi. No functional disturbance in bone marrow; WBC at least 3,000/mm3, Platelet count of atleast125,000/mm3\.
  • vii. No functional disturbance in liver; Bilirubin less than 2\.5 mg/dL, PT\-INR \< 1\.5
  • viii. No function disturbance in kidney; Creatinine no greater than 1\.5 times upper limit of normal.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials